FCM
OPTN

Farallon Capital Management’s OptiNose OPTN Stock Holding History

Farallon Capital Management’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-52,032
Closed -$3.5M – 122
2020
Q1 		$3.5M Sell
52,032
-7,968
-13% -$803K 0.03% 90
2019
Q4 		$8.3M Buy
+60,000
New +$7.78M 0.06% 100

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Farallon Capital Management's OPTN Position: Q2 2020 in Review

Farallon Capital Management sold out of OptiNose (OPTN) in Q2 2020, closing a stake of 52,032 shares — an estimated $3.5M sold.

Farallon Capital Management first reported a position in OPTN in Q4 2019 and held it in 2 quarters. The position peaked at $8.3M in Q4 2019. 72 funds tracked by Wall St. Rank hold OPTN as of Q2 2020.

  • Farallon Capital Management reported no remaining OptiNose position as of Q2 2020 after selling out during the quarter.
  • Farallon Capital Management sold 52,032 OptiNose shares in Q2 2020, an estimated $3.5M.
  • Farallon Capital Management first reported a position in OptiNose in Q4 2019 and held it in 2 quarters.
  • Farallon Capital Management's OptiNose position peaked at $8.3M in Q4 2019.
  • 72 funds tracked by Wall St. Rank held OptiNose as of Q2 2020.

Based on Farallon Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.